Dendritic cells as therapeutic targets in neuroinflammation


Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disorder of the central nervous system characterized by infiltration of immune cells and progressive damage to myelin sheaths and neurons. There is still no cure for the disease, but drug regimens can reduce the frequency of relapses and slightly delay progression. Myeloid cells… (More)
DOI: 10.1007/s00018-016-2170-9


1 Figure or Table